Your browser doesn't support javascript.
loading
The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
Qin, Jichao; Liu, Xin; Laffin, Brian; Chen, Xin; Choy, Grace; Jeter, Collene R; Calhoun-Davis, Tammy; Li, Hangwen; Palapattu, Ganesh S; Pang, Shen; Lin, Kevin; Huang, Jiaoti; Ivanov, Ivan; Li, Wei; Suraneni, Mahipal V; Tang, Dean G.
Afiliación
  • Qin J; Department of Molecular Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park, Smithville, TX 78957, USA.
Cell Stem Cell ; 10(5): 556-69, 2012 May 04.
Article en En | MEDLINE | ID: mdl-22560078
ABSTRACT
Prostate cancer (PCa) is heterogeneous and contains both differentiated and undifferentiated tumor cells, but the relative functional contribution of these two cell populations remains unclear. Here we report distinct molecular, cellular, and tumor-propagating properties of PCa cells that express high (PSA(+)) and low (PSA(-/lo)) levels of the differentiation marker PSA. PSA(-/lo) PCa cells are quiescent and refractory to stresses including androgen deprivation, exhibit high clonogenic potential, and possess long-term tumor-propagating capacity. They preferentially express stem cell genes and can undergo asymmetric cell division to generate PSA(+) cells. Importantly, PSA(-/lo) PCa cells can initiate robust tumor development and resist androgen ablation in castrated hosts, and they harbor highly tumorigenic castration-resistant PCa cells that can be prospectively enriched using ALDH(+)CD44(+)α2ß1(+) phenotype. In contrast, PSA(+) PCa cells possess more limited tumor-propagating capacity, undergo symmetric division, and are sensitive to castration. Altogether, our study suggests that PSA(-/lo) cells may represent a critical source of castration-resistant PCa cells.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Células Madre Neoplásicas / Adenocarcinoma / Antígenos de Diferenciación / Antígeno Prostático Específico Tipo de estudio: Diagnostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Cell Stem Cell Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Células Madre Neoplásicas / Adenocarcinoma / Antígenos de Diferenciación / Antígeno Prostático Específico Tipo de estudio: Diagnostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Cell Stem Cell Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos